Back to Journals » International Journal of General Medicine » Volume 14

The Association of Waist Circumference and the Risk of Deep Vein Thrombosis

Authors Lin C, Sun L, Chen Q

Received 21 October 2021

Accepted for publication 22 November 2021

Published 2 December 2021 Volume 2021:14 Pages 9273—9286

DOI https://doi.org/10.2147/IJGM.S344902

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Scott Fraser



Churong Lin,1,* Ling Sun,2,* Qinchang Chen2

1Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, People’s Republic of China; 2Department of Pediatric Cardiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Structural Heart Disease, Guangzhou, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Qinchang Chen
Department of Pediatric Cardiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Structural Heart Disease, No. 106 Zhongshan Road 2, Yuexiu District, Guangzhou, 510080, People’s Republic of China
Email [email protected]

Objective: In this study, we aimed to use a two sample Mendelian randomization (MR) method to identify a potentially causality between waist circumference and the risk of deep vein thrombosis (DVT).
Methods: With a two‐sample MR approach, we analyzed the summary data. The main analysis was performed by using the summary genetic data from two large consortium cohorts. Three MR approaches were used to explore MR estimates of waist circumference for DVT (inverse‐variance weighted [IVW] approach, weighted median method and MR‐Egger method). A total of 224 single nucleotide polymorphisms (SNPs) were identified associated with the level of waist circumference at statistical significance (P < 5*10− 8; linkage disequilibrium r2 < 0.1).
Results: The result of IVW indicated the positive association between waist circumference and the risk of DVT (OR 1.012, 95% CI 1.009– 1.014, P 7.627E-17). The other two methods were observed with consistent result. MR-Egger regression analysis indicated that no evidence for the presence of directional horizontal pleiotropy. Additionally, DVT was not a causal factor for waist circumference.
Conclusion: In summary, we used the GWAS genetic data from two large consortium cohorts and indicated the positive association between waist circumference and DVT. Further researches are needed to investigate potential mechanism and clarify the role of waist circumference on DVT.

Keywords: waist circumference, deep vein thrombosis, coronary heart disease, Mendelian randomization, causality, MR, DVT

Introduction

As a subset of venous thromboembolism (VTE), deep vein thrombosis (DVT) is the medical condition when thrombus formation occurs in deep veins, occupying two-third of VTE cases.1,2 Once the DVT falls off, it may block the pulmonary artery and form a fatal pulmonary embolism, which is an important cause of abnormal death in hospitalized patients.3 Coronavirus disease 2019 (COVID-19) is an ongoing outbreak of respiratory illness worldwide.4 Coagulation abnormalities and thromboembolism are becoming common complications in critically ill patients with COVID-19.5,6 The high incidence of DVT in patients with COVID-19 has attracted the attention of researchers and clinicians. Exploring the risk factors of the DVT is even more important at present.

Obesity has been demonstrated with increased risk of DVT in several researches.7–9 Recently, some studies have found that abdominal obesity might be a better predictor of DVT while waist circumference was the crucial indicator to evaluate abdominal obesity.10,11 Relevant reports were mostly conventional retrospective observation studies, which are inevitably interfered by reverse causality and confounding factors.12 Randomized controlled trials (RCTs) often require lots of time and money, and may involve ethical issues.13 In recent years, Mendelian randomization (MR) have been widely used in causal inferences of exposure factors and outcomes.14–16 Compared with RCTs, MR is more economical and cost-effective. However, there is no relevant reports of MR studies on abdominal obesity and DVT.

In this study, we aimed to determine the potential causal relationship between waist circumference and the risk of DVT by using MR analysis.

Materials and Methods

Genetic Variants Associated with Waist Circumference

The genetic variants associated with waist circumference was assessed from the Neale lab consortium, which consisted of 336,639 participants and 10,894,596 single nucleotide polymorphisms (SNPs). The detail of the consortium was shown in Table 1. As with most MR studies, the selection criteria for SNP was set as “P < 5×10-8, linkage disequilibrium r2 < 0.1” to decrease the impact of linkage disequilibrium.14,15 Finally, there were 229 SNPs met the above criteria.

Table 1 Details of the Traits Used in the Study

Genetic Variants Associated with DVT

The summary data for DVT was extracted from Medical research council-Integrative Epidemiology Unit (MER-ICU) consortium. There were 9241 DVT patients and 453,692 controls in this consortium. Apart from 5 SNPs (rs11208779, rs11666480, rs12335914, rs13264909, rs1454687) not found in MER-ICU, the remaining 224 SNPs were included in the analysis.

Estimation of the Causal Relationship

Two-sample MR can be used to analysis the data without contacting with clinical individual patients.17 We utilized a R (version 3.4.2) package “TwoSampleMR” (version 0.3.4) to implement operations. We estimated the causal effect of waist circumference on DVT and harnessed the statistical/6 power of pre-existing GWAS analyses with the SNP-exposure effects and the SNP-out-come effects which are obtained from different studies. Summary data were extracted from GWAS through MR-Base platform.18 Three MR approaches were used to explore MR estimates of waist circumference for DVT (inverse‐variance weighted [IVW] approach, weighted median method and MR‐Egger method). At first, we carried out a random-effects IVW meta-analysis by regressing the SNP–waist circumference associations against the SNP–DVT associations. The inverse-variance weighted mean of ratio estimates was calculated from 224 instruments. Fixed effects IVW assumed none of the SNPs exhibit horizontal pleiotropy while random effects IVW allows each SNP having different mean effects.18,19 Secondly, by using weighted median methods, we found the weighted empirical distribution function of ratio estimates of SNPs selected. Median-based estimator had the advantage that only half of the SNPs needed to be valid instruments, which meant that the other SNPs might exhibit no horizontal pleiotropy, no association with confounders or robust associations with the exposure, to make sure the causal effect to be unbiased. Moreover, it allowed stronger SNPs to contribute more towards the estimate.18,20 Third, MR-Egger analysis was implemented to assume that the horizontal pleiotropy had no association with the SNP-exposure effects.20 When adapting the IVW analysis, MR-Egger allowed a non-zero intercept and unbalanced horizontal pleiotropy across all SNPs. MR-Egger regression could return an unbiased causal effect even all the SNPs were invalid instruments. It helped to figure out weighted linear regression of SNP–waist circumference risk against SNP–DVT effect estimates. The causal effect of DVT on waist circumference was also investigated by these three methods.

Sensitivity Analysis

Leave-one-out method that eliminated the included SNPs one by one and calculated the effect of the remaining instrumental variables to find the decisive SNPs, was applied in the sensitivity analysis. The intercept in MR-Egger was calculated to check the presence of directional horizontal pleiotropy.

Results

Detail Information of the Selected SNPs

Table 2 showed the detail information of these 224 SNPs, consisting of the name, effect allele (EA), chromosome location, effect allele frequency (EAF), the estimations of the associations both with waist circumference and DVT, and so on. There were 29 SNPs significantly associated with the risk of DVT, namely rs10100245 (β-0.0010; SE 0.0003; P 0.0005), rs10128597 (β −0.0010; SE 0.0003; P 0.0008), rs10172196 (β 0.0010; SE 0.0003; P 0.0011), rs1019240 (β 0.0013; SE 0.0004; P 0.0011), rs10236214 (β 0.0011; SE 0.0003; P 0.0012), rs10237306 (β 0.0011; SE 0.0003; P 0.0019), rs10269774 (β 0.0009; SE 0.0003; P 0.0046), rs10423928 (β −0.0008; SE 0.0003; P 0.0110), rs10459088 (β 0.0008; SE 0.0003; P 0.0120), rs1056441 (β 0.0007; SE 0.0003; P 0.0150), rs10787738 (β −0.0008; SE 0.0003; P 0.0180), rs10803762 (β −0.0007; SE 0.0003; P 0.0190), rs10938398 (β −0.0007; SE 0.0003; P 0.0190), rs10957088 (β −0.0008; SE 0.0004; P 0.0200), rs10992841 (β 0.0008; SE 0.0004; P 0.0220) rs11012732 (β 0.0009; SE 0.0004; P 0.0250), rs11039266 (β −0.0008; SE 0.0004; P 0.0260), rs11099020 (β −0.0007; SE 0.0003; P 0.0260), rs11150745 (β 0.0009; SE 0.0004; P 0.0290), rs111640872 (β 0.0007; SE 0.0003; P 0.0330), rs112566467 (β 0.0006; SE 0.0003; P 0.0360), rs11474838 (β −0.0006; SE 0.0003; P 0.0400), rs1154988 (β −0.0006; SE 0.0003; P 0.0410), rs1159974 (β 0.0011; SE 0.0005; P 0.0410), rs11636611 (β −0.0006; SE 0.0003; P 0.0430), rs11642015 (β −0.0007; SE 0.0004; P 0.0450), rs11653367 (β −0.0006; SE 0.0003; P 0.0460), rs11757278 (β −0.0006; SE 0.0003; P 0.0460) and rs11764337 (β 0.0009; SE 0.0005; P 0.0490). In this analysis, the F statistic was 878, which was larger than 10 and able to suppress the interference of weak instrumental variables.21

Table 2 Associations of the Included SNPs with Waist Circumference and the Risk of DVT

Causal Effect of Waist Circumference on DVT

The result of IVW indicated the positive association between waist circumference and the risk of DVT (OR 1.012, 95% CI 1.009–1.014, P 7.627E-17) while the consistent result was observed in weighted median (OR 1.012, 95% CI 1.007–1.016, P 1.048E-07) and MR-Egger (OR 1.014, 95% CI 1.005–1.022, P 0.002) in Table 3. Figures 1 and 2 also presented the same statistical result.

Table 3 MR Estimates of the Associations Between Waist Circumference and Risk of DVT

Figure 1 Forest plot of the causal effect of waist circumference on DVT. Black points represent the log odds ratio for osteoarthritis per standard deviation increase in waist circumference, which is produced by using each SNP selected as a separate instrument. Red points show the combined causal estimate using all SNPs together as a single instrument, using the three different MR methods. Horizontal line segments denote 95% confidence intervals of the estimate.

Figure 2 Scatter plot of the causal effect of waist circumference on DVT. The plot presents the effect sizes of the SNP–waist circumference association (x-axis, standard deviation units) and the SNP–DVT association (y-axis, log [odds ratio]) with 95% confidence intervals. The regression slopes of the lines correspond to causal estimates using the three MR methods.

Sensitivity Analysis

For the MR-Egger regression, the presence of directional horizontal pleiotropy was not observed because the intercept was close to zero and P values was larger than 0.05 (intercept = −3.9E-05, P = 0.616) (Table 4). The method of leave-one-analysis indicated that there was no decisive SNP to reverse the result of causal inference (Figure 3).

Table 4 MR‐Egger Pleiotropy Test of the Associations Between Waist Circumference and Risk of DVT

Figure 3 Forest plot of the causal effect of waist circumference onDVT. Black points represent the log odds ratio for waist circumference by DVT, which is produced by using each SNP selected as a separate instrument. Red points show the combined causal estimate using all SNPs together as a single instrument, using the three different MR methods. Horizontal line segments denote 95% confidence intervals of the estimate.

Causal Effect of DVT on Waist Circumference

As presented in Table 5, DVT was not causally associated with the level of waist circumference (OR 1.198, 95% CI 0.719‐1.996, P = 0.487). After weighted median and MR-Egger were applied, the consistent result was also observed (OR 1.273, 95% CI 0.750–2.160, P 0.906; OR 1.064, 95% CI 0.393–2.878, P 0.371).

Table 5 MR Estimates of the Associations Between DVT and Waist Circumference

Discussion

DVT is a common and frequently-occurring disease in clinical practice, and the incidence is increasing year by year. People with DVT might lead to disability and cause death for severe cases, which seriously affect the prognosis and quality of life of patients. In present study, we explored the causal association between waist circumference and DVT through the two-sample MR analysis. The result indicated that higher level of waist circumference was causally associated with a higher risk of DVT while DVT did not contribute to the level of waist circumference. The finding highlighted the great importance of prevention and screening in the patients with abdominal obesity, especially during the COVID-19 pandemic.

Against the background of a sharp increase in obesity incidence worldwide, obesity has been the independent risk factors of DVT for long.22,23 The MR research from Denmark demonstrated the causal relationship between obesity and risk of DVT while similar result was observed in another MR study.24,25 Recently, abdominal obesity was recommended as the more suitable predictor for DVT in several researches. Yuan and his colleagues adjusted the factor of waist circumference and found that the association between body mass index (BMI) and DVT was relativity weakened, indicating that waist circumference might be the preferable indicator of DVT.10 A Swedish study found that abdominal obesity was an independent risk factor for middle-aged men in community.26 Borch et al27 provided evidence for the abdominal obesity as the pivotal risk factor among the individual components of the metabolic syndrome for the risk of VTE. It is with regret that few researches mentioned above were not able to clearly demonstrate the causal relationship due to the evidence from conventional observational studies. There were limited researches to explore the causal relationship between abdominal obesity and DVT. In present study, we performed a two-sample MR analysis to investigate the causal relationship between waist circumference and DVT. Odds ratio of 1.012 in IVW indicated that 1% higher waist circumference was associated with a 1.012‐fold risk of DVT. In the other two methods, the similar results were also shown. Though the clinical relevance was relatively modest, the present research showed that abdominal obesity was a causal risk factor in the risk of DVT. Unlike the previous studies, reverse causality and confounding factors can be well avoided due to the application of a two sample MR method. Several recent studies have used the MR analysis to found that genetic variants for waist circumference were causally associated with other outcomes, such as coronary heart disease, type II diabetes mellitus, lower gray matter volume and so on.14,27,28 Till now, we were the first to investigate the association between waist circumference and DVT through the method of two-sample MR analysis. Moreover, a large sample size (more than 400 thousand) reduced the bias from weak instrumental variables and provided enough power to robust causal detection.

Although the mechanism of abdominal obesity and DVT remains unclear, several possible mechanisms may explain the causal association. More than a century ago, Rudolf Virchow came up with three critical factors, venous stasis, activation of blood clotting, and venous damage.29 As the key component in metabolic syndrome, abdominal obesity plays a role in the insulin resistance while body fat distribution is a determined factor in insulin resistance.30 In comparison with subcutaneous adipose tissue, the abdominal fat had greater ability in insulin resistance, in which the balance of nitric oxide (NO) production and endothelin-1 secretion is broken, leading to the damage of endothelial cells.31 Adipocytes secrete inflammatory factors, such as IL-6, MCP-1, MCP-1 and so on. Overexpression of MCP-1 leads to increased free fatty acids in plasma, increases the recruitment of macrophages and the expression of inflammatory cytokines, then the coagulation system is activated.32 In addition, central obesity has been demonstrated with elevated intra-abdominal pressure and decreased flow velocity of venous blood, thus is more likely to form DVT.33,34 The patients with abdominal obesity are more likely with less physical activity, which might lead to the formation of DVT. Fat mass and obesity-associated gene (FTO) rs11642015 polymorphism was found significantly associated with risk of DVT in present study. Elevated FTO expression can decrease the expression of AKT phosphorylation in endothelial cells,35 which might lead to the dysfunction of endothelial and the development of DVT. It is a remarkable fact that the role of the other SNPs is still not clear. Therefore, further researches are needed to explore the potentially biological pathways in the progression of DVT.

Our analysis had several important strengths. First, compared with the traditional observational studies, MR analysis can avoid the reverse causality between exposure and outcome and not be affected by classical confounding factors. Larger sample size can bring more accurate estimation of causality. Second, three statistical approaches (IVW random-effect, weighted median and MR-Egger regression) were performed to test the causal relationship and make our finding more reliable. Horizontal pleiotropy might affect the validity of result. The consistency in the findings from these four different methods helps to adjust for pleiotropy. Third, our analysis is more economical and time-saving. There were also some limitations in this analysis. First, 224 SNPs were finally included in this analysis and invalid instrument variables might arise, which results in the biased estimates for causal effect and increases type I error rates.36 However, the result of MR Egger was coincident with the other methods, indicating the robustness of the findings. Second, for the limitation of summary data, we were not able to perform further subgroup analysis or mechanism of action. Third, the data for both exposure and outcome were extracted from European consortiums. Therefore, variations in genetic background are various among different populations and ethnicities, further researches are needed to investigate whether the conclusion can be genialized to other races.37

Conclusion

In summary, we used the GWAS genetic data from two large consortium Cohorts and indicated the positive association between waist circumference and the risk of DVT. Further researches are needed to investigate potential mechanism and clarify the role of waist circumference in DVT.

Ethics Approval and Informed Consent

There were no patients involved in the research design, recruitment or conduct, so the ethical approval was waived by ethic committee of Guangdong Provincial People’s Hospital. No participants were requested to advise on interpretation or writing up of results. There are no plans to disseminate the results of the research to study participants or the relevant patient community.

Funding

This research was funded by the Technology Planning Project of Guangdong Province (2018KJY2017).

Disclosure

The authors declare that they have no competing interests.

References

1. Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320(15):1583–1594. doi:10.1001/jama.2018.14346

2. Kruger PC, Eikelboom JW, Douketis JD, et al. Deep vein thrombosis: update on diagnosis and management. Med J Aust. 2019;210(11):516–524. doi:10.5694/mja2.50201

3. Kearon C, de Wit K, Parpia S, et al. Diagnosis of pulmonary embolism with d-dimer adjusted to clinical probability. N Engl J Med. 2019;381(22):2125–2134. doi:10.1056/NEJMoa1909159

4. Wang T, Chen R, Liu C, et al. Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19. Lancet Haematol. 2020;7(5):e362–e363. doi:10.1016/S2352-3026(20)30109-5

5. Gregson J, Kaptoge S, Bolton T, et al. Cardiovascular risk factors associated with venous thromboembolism. JAMA Cardiol. 2019;4(2):163–173. doi:10.1001/jamacardio.2018.4537

6. Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440. doi:10.1016/S2352-3026(20)30145-9

7. Klarin D, Emdin CA, Natarajan P, et al. Genetic analysis of venous thromboembolism in UK Biobank identifies the ZFPM2 locus and implicates obesity as a causal risk factor. Circ Cardiovasc Genet. 2017;10(2):e001643. doi:10.1161/CIRCGENETICS.116.001643

8. Horvei LD, Brækkan SK, Mathiesen EB, et al. Obesity measures and risk of venous thromboembolism and myocardial infarction. Eur J Epidemiol. 2014;29(11):821–830. doi:10.1007/s10654-014-9950-z

9. Glise Sandblad K, Jern S, Åberg M, et al. Obesity in adolescent men increases the risk of venous thromboembolism in adult life. J Intern Med. 2020;287(6):734–745. doi:10.1111/joim.13044

10. Yuan S, Bruzelius M, Xiong Y, et al. Overall and abdominal obesity in relation to venous thromboembolism. J Thromb Haemost. 2021;19(2):460–469. doi:10.1111/jth.15168

11. Matos MF, Lourenço DM, Orikaza CM, et al. Abdominal obesity and the risk of venous thromboembolism among women: a potential role of interleukin-6. Metab Syndr Relat Disord. 2013;11(1):29–34. doi:10.1089/met.2012.0077

12. Thuesen ACB, Vaag A. Perspectives on diabetes mortality as the result of residual confounding and reverse causality by common disease. Diabetes Obes Metab. 2018;20(6):1342–1349. doi:10.1111/dom.13238

13. Goldstein CE, Weijer C, Brehaut JC, et al. Ethical issues in pragmatic randomized controlled trials: a review of the recent literature identifies gaps in ethical argumentation. BMC Med Ethics. 2018;19(1):1–10. doi:10.1186/s12910-018-0253-x

14. Chen Q, Li L, Yi J, et al. Waist circumference increases risk of coronary heart disease: evidence from a Mendelian randomization study. Mol Genet Genomic Med. 2020;8(4):e1186. doi:10.1002/mgg3.1186

15. He Y, Zheng C, He MH, et al. The causal relationship between body mass index and the risk of osteoarthritis. Int J Gen Med. 2021;14:2227. doi:10.2147/IJGM.S314180

16. Lamina C, Kronenberg F. Estimation of the required lipoprotein (a)-lowering therapeutic effect size for reduction in coronary heart disease outcomes: a Mendelian randomization analysis. JAMA Cardiol. 2019;4(6):575–579. doi:10.2147/IJGM.S314180

17. Pierce BL, Burgess S. Efficient design for Mendelian randomization studies: subsample and 2-sample instrumental variable estimators. Am J Epidemiol. 2013;178:1177–1184. doi:10.1093/aje/kwt084

18. Hemani G, Zheng J, Elsworth B, et al. The MR-base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408. doi:10.7554/eLife.34408

19. Marín-Martínez F, Sánchez-Meca J. Weighting by inverse variance or by sample size in random-effects meta-analysis. Educ Psychol Meas. 2010;70:56–73. doi:10.1177/0013164409344534

20. Bowden J, Davey Smith G, Haycock PC, et al. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–314. doi:10.1002/gepi.21965

21. Burgess S, Thompson SG; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40(3):755–764. doi:10.1093/ije/dyr036

22. Sloan M, Sheth N, Lee GC. Is obesity associated with increased risk of deep vein thrombosis or pulmonary embolism after hip and knee arthroplasty? A large database study. Clin Orthop Relat Res. 2019;477(3):523. doi:10.1097/CORR.0000000000000615

23. Vučković BA, Cannegieter SC, van Hylckama Vlieg A, et al. Recurrent venous thrombosis related to overweight and obesity: results from the MEGA follow‐up study. J Thromb Haemost. 2017;15(7):1430–1435. doi:10.1111/jth.13710

24. Tan JS, Liu NN, Guo TT, et al. Genetically predicted obesity and risk of deep vein thrombosis. Thromb Res. 2021;207:16–24. doi:10.1016/j.thromres.2021.08.026

25. Klovaite J, Benn M, Nordestgaard BG. Obesity as a causal risk factor for deep venous thrombosis: a M endelian randomization study. J Intern Med. 2015;277(5):573–584. doi:10.1111/joim.12299

26. Hansson PO, Eriksson H, Welin L, et al. Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913. Arch Intern Med. 1999;159(16):1886–1890. doi:10.1001/archinte.159.16.1886

27. Borch KH, Braekkan SK, Mathiesen EB, et al. Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study. J Thromb Haemost. 2009;7(5):739–745. doi:10.1111/j.1538-7836.2008.03234.x

28. Li K, Feng T, Wang L, et al. Causal associations of waist circumference and waist-to-hip ratio with type II diabetes mellitus: new evidence from Mendelian randomization. Mol Genet Genomics. 2021;296(3):605–613. doi:10.1007/s00438-020-01752-z

29. Debette S, Wolf C, Lambert JC, et al. Abdominal obesity and lower gray matter volume: a Mendelian randomization study. Neurobiol Aging. 2014;35(2):378–386. doi:10.1016/j.neurobiolaging.2013.07.022

30. Bagot CN, Arya R. Virchow and his triad: a question of attribution. Br J Haematol. 2008;143(2):180–190. doi:10.1111/j.1365-2141.2008.07323.x

31. Shim YS, Kang MJ, Oh YJ, et al. Association of serum ferritin with insulin resistance, abdominal obesity, and metabolic syndrome in Korean adolescent and adults: the Korean National Health and Nutrition Examination Survey, 2008 to 2011. Medicine. 2017;96:8. doi:10.1097/MD.0000000000006179

32. Bouchouirab FZ, Fortin M, Noll C, et al. Plasma palmitoyl-carnitine (AC16: 0) is a marker of increased postprandial nonesterified incomplete fatty acid oxidation rate in adults with type 2 diabetes. Can J Diabetes. 2018;42(4):382–388. e1. doi:10.1016/j.jcjd.2017.09.002

33. Ghodoosi N, Mirzababaei A, Rashidbeygi E, et al. Associations of dietary inflammatory index, serum levels of MCP-1 and body composition in Iranian overweight and obese women: a cross-sectional study. BMC Res Notes. 2020;13(1):1–7. doi:10.1186/s13104-020-05390-x

34. Lteif A, Vaishnava P, Baron AD, et al. Endothelin limits insulin action in obese/insulin-resistant humans. Diabetes. 2007;56(3):728–734. doi:10.2337/db06-1406

35. Krüger N, Biwer LA, Good ME, et al. Loss of endothelial FTO antagonizes obesity-induced metabolic and vascular dysfunction. Circ Res. 2020;126(2):232–242. doi:10.1161/CIRCRESAHA.119.315531

36. Burgess S, Thompson S. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol. 2013;42:1134–1144. doi:10.1093/ije/dyt093

37. Tan JS, Yan XX, Wu Y, et al. Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism. Int J Cardiol. 2021;331:236–242. doi:10.1016/j.ijcard.2021.01.073

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.